Cargando…
Neuropathology of drug addictions and substance misuse. Volume 3, General processes and mechanisms, prescription medications, caffeine and Areca, polydrug misuse, emerging addictions and non-drug addictions /
"Neuropathology of Drug Addictions and Substance Misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions "is the third of three volumes in this informative series and offers a comprehensi...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London ; San Diego, CA :
Academic Press,
[2016]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000007i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn948247484 | ||
| 003 | OCoLC | ||
| 005 | 20231120112105.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 160429s2016 enk ob 001 0 eng d | ||
| 040 | |a IDEBK |b eng |e rda |e pn |c IDEBK |d N$T |d OPELS |d N$T |d OCLCF |d EBLCP |d COO |d YDXCP |d OCLCQ |d UPM |d NLE |d U3W |d TEFOD |d D6H |d KOS |d OCLCO |d OCLCA |d MERER |d OCLCO |d CUY |d OCLCQ |d YDX |d OCLCO |d AU@ |d OCLCO |d UKMGB |d OCLCO |d OCLCA |d S2H |d OCLCQ |d VLY |d OCLCO |d REDDC |d VJ2 |d OCLCO |d YDX |d OCLCQ |d OCL |d OCLCO | ||
| 015 | |a GBB7N9217 |2 bnb | ||
| 016 | 7 | |a 018617877 |2 Uk | |
| 019 | |a 949752791 |a 950464091 |a 1015339423 |a 1117221538 |a 1162230210 |a 1229063807 |a 1229133958 |a 1257363646 |a 1259585969 |a 1288251481 | ||
| 020 | |a 9780128006771 |q (electronic book) | ||
| 020 | |a 0128006773 |q (electronic book) | ||
| 020 | |z 012800634X | ||
| 020 | |z 9780128006344 | ||
| 020 | |a 012800634X | ||
| 020 | |a 9780128006344 | ||
| 024 | 3 | |a 9780128006344 | |
| 035 | |a (OCoLC)948247484 |z (OCoLC)949752791 |z (OCoLC)950464091 |z (OCoLC)1015339423 |z (OCoLC)1117221538 |z (OCoLC)1162230210 |z (OCoLC)1229063807 |z (OCoLC)1229133958 |z (OCoLC)1257363646 |z (OCoLC)1259585969 |z (OCoLC)1288251481 | ||
| 050 | 4 | |a RC564 |b .N483 2016 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.86/075 |2 23/eng/20221031 |
| 082 | 0 | 4 | |a 616.86 |2 23 |
| 245 | 0 | 0 | |a Neuropathology of drug addictions and substance misuse. |n Volume 3, |p General processes and mechanisms, prescription medications, caffeine and Areca, polydrug misuse, emerging addictions and non-drug addictions / |c edited by Victor R. Preedy. |
| 246 | 3 | 0 | |a General processes and mechanisms, prescription medications, caffeine and Areca, polydrug misuse, emerging addictions and non-drug addictions |
| 264 | 1 | |a London ; |a San Diego, CA : |b Academic Press, |c [2016] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Front Cover; Neuropathology of Drug Addictionsand Substance Misuse; Evolve Page ; Neuropathology of Drug Addictions and Substance Misuse: Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions; Copyright; Contents; List of Contributors; Preface; Acknowledgments; I -- Principles of Addictions, Overviews, Detailed Processes and Mechanisms; A -- General Aspects; 1 -- Drugs and the Human Envirome; INTRODUCTION; THE HUMAN ENVIROME PROJECT; HISTORY AND BACKGROUND OF CURRENT POLITICAL ENVIRONMENTS. | |
| 505 | 8 | |a OTHER MACRO-LEVEL FACETS OF THE CURRENT INTERNATIONAL POLICY REGIMEDRUG POLICY EVALUATION, PIECE BY PIECE; CONCLUSIONS; SUMMARY POINTS; REFERENCES; 2 -- Psychoactive Plants Used during Religious Rituals; INTRODUCTION; EVIDENCES AND FINDINGS; SUMMARY OF THE PSYCHOLOGICAL EFFECTS OF THE PSYCHOACTIVE PLANTS USED IN ANCIENT RELIGIOUS RITUALS; Lysergic Acid Diethylamide (LSD) and LSD-like Effects (in Mescaline, Psilocybin, DMT, Central Nervous System (CNS) Stimulants, i ... ; Opium (Narcotic Analgesics, Morphine); Cannabis sativa (THC); Ephedra (Ephedrine). | |
| 505 | 8 | |a Mandragora, Blue Water Lily (Atropine, Scopolamine), and Muscarine (Amanita Muscaria, Magic Mushrooms)Monoamine Oxidase Inhibitors (Peganum harmala; Harmine, Harmaline; Banisteriopsis caapi Vine); DMT (Ayahuasca Plants; Phalaris Species); 5-Hydroxy DMT (Bufotenin); Psilocybin (Magic Mushrooms); Ibogaine (Tabernanthe iboga); Salvia divinorum; Thujone (Wormwood; Artemisia absinthium); Mescaline (Peyote); DISCUSSION; Psychoactive Plants, H-ASCs, and Mystical Experience; What Can Be the Basis of Psychedelic Religious Experience?; APPLICATIONS TO OTHER ADDICTIONS AND SUBSTANCE MISUSE. | |
| 505 | 8 | |a DEFINITION OF TERMSKEY FACTS; SUMMARY POINTS; ACKNOWLEDGMENT; REFERENCES; 3 -- Substance Use Disorders and Comorbid Mental Illness: A Focus on Epidemiological Data Regarding Mood and Anxiety Disorders; INTRODUCTION; MOOD AND ANXIETY DISORDERS AMONG INDIVIDUALS WITH SUDS; Mood and Anxiety Disorders among Individuals with AUD; Mood and Anxiety Disorders among Individuals with Cannabis Use Disorders; Mood and Anxiety Disorders among Individuals with Opioid Use Disorders; Mood and Anxiety Disorders among Individuals with Methamphetamine Use Disorders. | |
| 505 | 8 | |a Mood and Anxiety Disorders among Individuals with Cocaine Use DisordersPREVALENCE OF SUDS AMONG INDIVIDUALS WITH MOOD AND ANXIETY DISORDERS; SUDs among Individuals with MDD; SUDs among Individuals with BPD; SUDs among Individuals with SAD; SUDs among Individuals with GAD; SUDs among Individuals with Panic Disorder; LONGITUDINAL DATA-INCIDENCE OF SUDS AMONG INDIVIDUALS WITH MOOD AND ANXIETY DISORDERS; Unipolar Mood Disorders and the Future Development of SUDs; BPD and the Future Development of SUDs; SAD and the Future Development of SUDs; GAD, Panic Disorder, and the Future Development of SUDs. | |
| 520 | 8 | |a "Neuropathology of Drug Addictions and Substance Misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions "is the third of three volumes in this informative series and offers a comprehensive examination of the adverse consequences of the most common drugs of abuse. Each volume serves to update the reader s knowledge on the broader field of addiction as well as to deepen understanding of specific addictive substances. "Volume 3" addresses prescription medications, caffeine, polydrug misuse, and non-drug addictions. Each section provides data on the general, molecular, cellular, structural, and functional neurological aspects of a given substance, with a focus on the adverse consequences of addictions. Research shows that the neuropathological features of one addiction are often applicable to those of others, and understanding these commonalties provides a platform for studying specific addictions in more depth and may ultimately lead researchers toward new modes of understanding, causation, prevention and treatment. However, marshalling data on the complex relationships between addictions is difficult due to the myriad of material and substances. Offers a modern approach to understanding the pathology of substances of abuse, offering an evidence-based ethos for understanding the neurology of addictionsFills an existing gap in the literature by serving as a one-stop-shopping synopsis of everything to do with the neuropathology of drugs of addiction and substance misuseIncludes in each chapter: list of abbreviations, abstract, introduction, applications to other addictions and substance misuse, mini-dictionary of terms, summary points, 6+ figures and tables, full referencesOffers coverage of preclinical, clinical, and population studies, from the cell to whole organs, and from the genome to whole body." | |
| 504 | |a Includes bibliographical references at the end of each chapters and index. | ||
| 588 | 0 | |a Online resource; title from digital title page (viewed on October 31, 2022). | |
| 650 | 0 | |a Substance abuse |x Pathophysiology. | |
| 650 | 0 | |a Nervous system |x Diseases. | |
| 650 | 0 | |a Substance abuse. | |
| 650 | 2 | |a Substance-Related Disorders |x physiopathology |0 (DNLM)D019966Q000503 | |
| 650 | 2 | |a Nervous System Diseases |0 (DNLM)D009422 | |
| 650 | 2 | |a Substance-Related Disorders |0 (DNLM)D019966 | |
| 650 | 6 | |a Polytoxicomanie. |0 (CaQQLa)000347301 | |
| 650 | 6 | |a Syst�eme nerveux |x Maladies. |0 (CaQQLa)201-0007359 | |
| 650 | 6 | |a Abus de substances psychoactives. |0 (CaQQLa)000347291 | |
| 650 | 7 | |a substance abuse. |2 aat |0 (CStmoGRI)aat300189230 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Substance abuse |x Pathophysiology |2 fast |0 (OCoLC)fst01136787 | |
| 650 | 7 | |a Nervous system |x Diseases |2 fast |0 (OCoLC)fst01036098 | |
| 650 | 7 | |a Substance abuse |2 fast |0 (OCoLC)fst01136767 | |
| 700 | 1 | |a Preedy, Victor R., |e editor. | |
| 776 | 0 | 8 | |i Print version: |a Preedy, Victor R. |t Neuropathology of Drug Addictions and Substance Misuse Volume 3 : General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. |d : Elsevier Science, �2016 |z 9780128006344 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128006344 |z Texto completo |